A new jab which allows cancer patients to be treated with just one injection is set to be rolled out by the NHS for 15 different types of the disease. Patients will be able to receive the immunotherapy in a vaccine, called nivolumab, in a treatment that will take just 15 minutes rather than spending an hour on an IV drip.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients who received only an immune-based treatment to help their own immune systems shrink their tumors—and no surgery, which is generally the standard treatment for them—showed no detectable signs of disease after two years.

The NHS has become the first health service in Europe to offer a new cancer jab that dramatically cuts treatment time. Patients will now receive their immunotherapy in just 5 minutes instead of up to an hour via an IV drip,